European Medicines Agency and United States Food and Drug Administration to share manufacturing site inspections

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) are launching an initiative to share work on inspections of manufacturing sites in each other's territories. The initiative, starting in January 2012, will enable the two authorities to rely on each other's inspection outcomes rather than carrying out separate inspections in duplicate.

EMA/FDA: Enhancing GMP inspection cooperation between the EMA and FDA: Moving from confidence-building to reliance upon http://www.ema.europa.eu/docs/en_GB/document_library/Other/2011/12/WC500118766.pdf

---